Dissolution enhancement of felodipine by amorphous nanodispersions using an amphiphilic polymer: insight into the role of drug–polymer interactions on drug dissolution

Development and characterization of cellulose–polymethacrylate mucoadhesive film for buccal delivery of carvedilol

(2013) Jaya Gopal Meher et al.   CARBOHYDRATE POLYMERS

Interaction of calcium sulfate with xanthan gum: Effect on in vitro bioadhesion and drug release behavior from xanthan gum based buccal discs of buspirone

(2013) A. Jaipal et al.   COLLOIDS AND SURFACES B-BIOINTERFACES

Current trends and future perspectives of solid dispersions containing poorly water-soluble drugs

(2013) Chau Le-Ngoc Vo et al.   EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS

New formulation approaches to improve solubility and drug release from fixed dose combinations: Case examples pioglitazone/glimepiride and ezetimibe/simvastatin

(2012) Thomas Taupitz et al.   EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS

Modeling the oral cavity: In vitro and in vivo evaluations of buccal drug delivery systems

(2012) Viralkumar F. Patel et al.   JOURNAL OF CONTROLLED RELEASE

Soluplus®: A novel polymeric solubilizer for optimization of Carvedilol solid dispersions: Formulation design and effect of method of preparation

(2012) Rehab N. Shamma et al.   POWDER TECHNOLOGY

Nanoparticles: A personal experience for formulating poorly water soluble drugs

(2009) Eugene R. Cooper   JOURNAL OF CONTROLLED RELEASE

Effects of Polymer Type and Storage Relative Humidity on the Kinetics of Felodipine Crystallization from Amorphous Solid Dispersions

(2009) Alfred C. F. Rumondor et al.   PHARMACEUTICAL RESEARCH

Evaluation of Drug-Polymer Miscibility in Amorphous Solid Dispersion Systems

(2009) Alfred C. F. Rumondor et al.   PHARMACEUTICAL RESEARCH

Development and Evaluation of Buccoadhesive Controlled Release Tablets of Lercanidipine

(2008) Shrikant Charde et al.   AAPS PHARMSCITECH

Amorphous Pharmaceutical Solids: Characterization, Stabilization, and Development of Marketable Formulations of Poorly Soluble Drugs with Improved Oral Absorption

(2008) Ping Gao   MOLECULAR PHARMACEUTICS